Since the onset of COVID-19, there has been an increase in alcohol consumption in the US.
For those recovering from or struggling with alcohol use disorder, there are resources available to help through these challenging times.
About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts ; a research and manufacturing facility in Athlone, Ireland ; and a manufacturing facility in Wilmington, Ohio . For more information, please visit Alkermes' website at www.alkermes.com.
Tweet me: Since the onset of #COVID19, there has been an increase in alcohol consumption in the US. For those recovering from or struggling with #alcoholusedisorder, there are resources available to help. Learn more via @NIDANews: https://bit.ly/3mHV95v @Alkermes
KEYWORDS: NASDAQ:ALKS, Alkermes, substance abuse, alcohol use disorder